Table 1. Correlation between CDKN2A expression of clinicopathological from hepatocellular carcinoma patients.

Clinicopathological factor	Number of cases	CDKN2A		χ2	P
		High expression	Low expression
Age
<55	117	68	49	0.546
≥55	254	164	90		0.428
Gender
Male	121	76	45	0.653
Female	250	156	94		0.483
TNM stage
I	158	103	55	6.735
II	86	55	31
III	127	74	53		0.032
Grade
I	56	32	24	5.675
II	177	104	73
III	124	84	40
IV	14	12	2		0.056
Survival status
Death	126	97	29	6.974
Survival	245	135	110		0.024

Data from TCGA database.